Skip to content
Bored Studies
Recruiting

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Endologix · NCT05064540

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 21+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
450
US sites recruiting
25
Study start
September 20, 2021
Record last updated
September 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints.

Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).

Being studied: Alto Abdominal Stent Graft System; FDA Approved EVAR AAA Graft Systems

Conditions: AAA; AAA - Abdominal Aortic Aneurysm

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Adult age 21 and older
  • Subjects with minimum of 2 year life expectancy
  • Subjects have signed the informed consent document
  • Subjects with unruptured infrarenal AAA who are assessed by the Investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the trial devices.
  • Patient must be able and willing to comply with all required follow-up exams.

Exclusion Criteria

  • Currently participating in another trial where the primary endpoint has not been reached yet.
  • Known allergy to any of the device components
  • Pregnant (females of childbearing potential only)
  • Known connective tissue disorders
  • Known active infection
  • Subjects with pre-existing EVAR, i.e., in need of repair/intervention of a previously failed EVAR.
  • Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.

Recruiting US locations

  • University of Arizona

    Tucson, AZ 85716

    Site contact: Karen Sanchez · kas10@arizona.edu

  • Washington Regional Medical Center

    Fayetteville, AR 72703

    Site contact: Callie McQueen · 479-463-7858 · cmcqueen@wregional.com

  • Central Arkansas Veterans Healthcare System

    Little Rock, AR 72205

    Site contact: Sandra Brock · 501-257-6906 · sandra.brock@va.gov

  • The Regents of the University of California, San Diego

    La Jolla, CA 92093

    Site contact: Kathleen Groh · (951)595-2347 · kagroh@health.ucsd.edu

  • Veterans Affairs San Diego Healthcare System

    San Diego, CA 92161

    Site contact: Annalicia Vargas · annalicia.vargas@va.gov

  • MedStar Washington Hospital Center

    Washington D.C., DC 20001

    Site contact: Kassaye Sesaba · 202-877-7452 · Kassaye.T.Sesaba@medstar.net

  • Jacksonville Center for Clinical Research

    Jacksonville, FL 32216

    Site contact: Lisa Joseph · 904.732.2217 · ljoseph@encoredocs.com

  • Radiology and Imaging Specialists

    Lakeland, FL 33801

    Site contact: Eve Johnson · 863-688-2334 · ejohnson@risimaging.com

  • Baptist Hospital of Miami, Miami Cardiac and Vascular Institute

    Miami, FL 33176

    Site contact: David Fernandez · 786-596-5392 · davidfer@baptisthealth.net

  • University of Louisville

    Louisville, KY 40202-1959

    Site contact: Leslie Haysley · (502) 852-2801 · leslie.haysley@louisville.edu

  • Tufts Medical Center

    Boston, MA 02111

    Site contact: Gaurav Das · 617-636-4990 · Gaurav.Das@tuftsmedicine.org

  • University of Missouri

    Columbia, MO 65212

    Site contact: Jennifer Randolph · 573-882-4387 · Randolphjl@health.missouri.edu

  • Newark Beth Israel Medical Center

    Newark, NJ 07112

    Site contact: Debra Cook · Debra.cook@rwjbh.org

  • Icahn School of Medicine at Mount Sinai

    New York, NY 10029-6574

    Site contact: Jack Waitz · 212-241-8250 · Jack.Waitz@mountsinai.org

  • Feinstein Institutes for Medical Research (Staten Island University Hospital/Northwell Health)

    Staten Island, NY 10305

    Site contact: Alexandra Pantea · 718-226-6438 · apantea@northwell.edu

  • The Cleveland Clinical Foundation

    Cleveland, OH 44106

    Site contact: Larissa Schaaf, RN · (216) 445-4437 · schaafl@ccf.org

  • Oregon Health Sciences University

    Portland, OR 97239

    Site contact: Amie Lorisch · lorischa@ohsu.edu

  • U.S. Department of Veterans Affairs, VA Portland Health Care System

    Portland, OR 97239

    Site contact: Jin Kim · jin.kim9@va.gov

  • Lehigh Valley Health Network

    Allentown, PA 18103

    Site contact: Deborah Mankos · 610-402-1635 · deborah.mankos@lvhn.org

  • University of Pennsylvania

    Philadelphia, PA 19104

    Site contact: Thomas Hebert · 973-454-3066 · thomas.hebert@pennmedicine.upenn.edu

  • Allegheny Health Network

    Pittsburgh, PA 15212

    Site contact: Sheila Bernardini · sheila.bernardini@ahn.org

  • Wellmont Cardiology Services

    Kingsport, TN 37660

    Site contact: Joshua Lester

  • The University of Texas Medical Branch at Galveston

    Galveston, TX 77555

    Site contact: Sana Malik · 409-747-7333 · sanmalik@utmb.edu

  • Houston Methodist Research Institute

    Houston, TX 77030

    Site contact: Solange Basagoitia · 713-441-0176 · smbasagoitia@houstonmethodist.org

  • Sentara Hospitals

    Norfolk, VA 23507

    Site contact: Kara Wiggins, MSN, RN · 757-388-7511 · KVWIGGIN@sentara.com

Study contacts (from the official record)

  • Noel DeSisto · 864-270-8524 · ndesisto@endologix.com
  • Sanjana Tabassum · stabassum@endologix.com
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through… (NCT05064540) | Bored Studies